SLC9A3
Sodium/hydrogen exchanger 3
Also known as: NHE-3, NHE3, SL9A3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48764
- Gene
- SLC9A3
- Ensembl
- ENSG00000066230
- Chromosome
- 5
- Canonical length
- 834 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is an epithelial brush border Na/H exchanger that uses an inward sodium ion gradient to expel acids from the cell. Defects in this gene are a cause of congenital secretory sodium diarrhea. Pseudogenes of this gene exist on chromosomes 10 and 22. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
834 residues, UniProt reviewed canonical sequence.
>P48764|SLC9A3
1 MWGLGARGPD RGLLLALALG GLARAGGVEV EPGGAHGESG GFQVVTFEWA HVQDPYVIAL
61 WILVASLAKI GFHLSHKVTS VVPESALLIV LGLVLGGIVW AADHIASFTL TPTVFFFYLL
121 PPIVLDAGYF MPNRLFFGNL GTILLYAVVG TVWNAATTGL SLYGVFLSGL MGDLQIGLLD
181 FLLFGSLMAA VDPVAVLAVF EEVHVNEVLF IIVFGESLLN DAVTVVLYNV FESFVALGGD
241 NVTGVDCVKG IVSFFVVSLG GTLVGVVFAF LLSLVTRFTK HVRIIEPGFV FIISYLSYLT
301 SEMLSLSAIL AITFCGICCQ KYVKANISEQ SATTVRYTMK MLASSAETII FMFLGISAVN
361 PFIWTWNTAF VLLTLVFISV YRAIGVVLQT WLLNRYRMVQ LEPIDQVVLS YGGLRGAVAF
421 ALVVLLDGDK VKEKNLFVST TIIVVFFTVI FQGLTIKPLV QWLKVKRSEH REPRLNEKLH
481 GRAFDHILSA IEDISGQIGH NYLRDKWSHF DRKFLSRVLM RRSAQKSRDR ILNVFHELNL
541 KDAISYVAEG ERRGSLAFIR SPSTDNVVNV DFTPRSSTVE ASVSYLLREN VSAVCLDMQS
601 LEQRRRSIRD AEDMVTHHTL QQYLYKPRQE YKHLYSRHEL TPTEDEKQDR EIFHRTMRKR
661 LESFKSTKLG LNQNKKAAKL YKRERAQKRR NSSIPNGKLP MESPAQNFTI KEKDLELSDT
721 EEPPNYDEEM SGGIEFLASV TKDTASDSPA GIDNPVFSPD EALDRSLLAR LPPWLSPGET
781 VVPSQRARTQ IPYSPGTFCR LMPFRLSSKS VDSFLQADGP EERPPAALPE STHMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC9A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 13
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 88 nTPM
Expression across tissuesHPA
Tissue
- colon: 88 nTPM
- kidney: 64 nTPM
- small intestine: 64 nTPM
- stomach: 47 nTPM
- duodenum: 43 nTPM
- gallbladder: 43 nTPM
Single-cell type
- loop of henle epithelial cells: 135 nCPM
- proximal tubule cells: 67 nCPM
- epicardial cells: 50 nCPM
- cardiomyocytes: 21 nCPM
- enterocytes: 13 nCPM
- basal keratinocytes: 12 nCPM
Immune cell
- naive CD4 T-cell: 3.9 nTPM
- memory CD4 T-cell: 3.3 nTPM
- naive CD8 T-cell: 3.2 nTPM
- T-reg: 2.7 nTPM
- gdT-cell: 2.6 nTPM
- memory CD8 T-cell: 2.4 nTPM
Brain region
- cerebellum: 18 nTPM
- cerebral cortex: 15 nTPM
- hippocampal formation: 15 nTPM
- pons: 13 nTPM
- medulla oblongata: 12 nTPM
- thalamus: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC9A3.
Disease | AllUniProt
Conditions SLC9A3 is implicated in, by any mechanism.
- Diarrhea 8, secretory sodium, congenital (DIAR8) MIM:616868
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 831 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital secretory sodium diarrhea 8
ReferencesPubMed · IEDB
Publications for SLC9A3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule.
1999 · J Biol Chem · RCR 2.4 · 102 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.49
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- monoatomic ion transport
- potassium ion transmembrane transport
- regulation of intracellular pH
- sodium ion import across plasma membrane
Molecular functions
- identical protein binding
- PDZ domain binding
- phosphatidylinositol binding
- potassium:proton antiporter activity
- sodium:proton antiporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC9A3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC9A3 as an antibody target. Whether an autoantibody or antibody against SLC9A3 could matter depends on whether native SLC9A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC9A3 is annotated at the cell surface, where native SLC9A3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC9A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...